Skip to contentSkip to navigation

The Pivot: Serology testing to track patients' exposure to SARS-CoV-2

|June 11, 2020

In this week’s episode of The Pivot, we speak with François Drolet, Director, Public Affairs at Roche Diagnostics, about the importance of antibody testing to help determine if a patient has been exposed to the SARS-CoV-2 virus and if the patient has developed antibodies against it.

Roche’s Elecsys® Anti-SARS-CoV-2 serology test was recently authorized under Health Canada's Interim Order making it available to Canadian laboratories, healthcare professionals and patients.

Watch and learn more about how antibody testing could have an impact on the understanding of the COVID-19 disease and influence the decision making in healthcare systems.

Click on the image above to view the video

View all episodes of The Pivot